EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Six approved drugs for alcohol use disorder: algorithms for their use according to the aims of treatment

Fabio Caputo iD, Teo Vignoli, Lisa Lungaro, Anna Costanzini, Alberto Casabianca, Giacomo Caio, Gianni Testino iD, Giovanni Addolorato iD, Roberto De Giorgio

Alcohol and Alcoholism · 20.07.2026 · 61 (5)

DOI: 10.1093/alcalc/agag052 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Alcohol and Alcoholism, online erschienen am 20.07.2026. Verfasst von Fabio Caputo und 8 weiteren Autor:innen. Beteiligte Einrichtung: Centre for the Study and Treatment of Alcohol-Related Diseases, Department of Translational Medicine, University of Ferrara, Via Borsari 46, 44121, F…. Hauptthemen laut MEDLINE: Alcohol Deterrents, Alcoholism, Algorithms. Die Arbeit nennt 66 Literaturangaben. Gefördert von: University of Ferrara.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The pharmacological management of alcohol use disorder (AUD) currently includes six medications approved by different regulatory agencies worldwide: acamprosate (ACM), naltrexone (NTX), nalmefene (NMF), disulfiram (DF), baclofen, and sodium oxybate (SO). Their optimal use should be aligned with the main aims of treatment, namely reduction of alcohol consumption and maintenance of complete abstinence.

Objectives

This brief review summarizes the role of these six approved medications in AUD treatment and proposes practical treatment algorithms according to treatment goals, mechanisms of action, and clinically relevant outcomes.

Methods

A focused narrative review of the literature was conducted, prioritizing meta-analyses, systematic reviews, randomized controlled trials, and relevant regulatory documents. Evidence on efficacy, safety, tolerability, and clinical applicability was interpreted pragmatically to support first-, second-, and third-line pharmacological strategies.

Results

For reducing alcohol intake, NMF or NTX are proposed as first-line pharmacotherapies, with baclofen considered as a second-line option when these agents are partially effective or ineffective. For maintaining abstinence, ACM is proposed as a first-line strategy. In selected clinical settings, including severe AUD, protracted alcohol withdrawal syndrome, high motivation for aversive treatment, or liver disease, SO, baclofen, DF, or NTX may serve as second-line options. Combined pharmacotherapy may be considered in highly adherent patients, whereas off-label drugs remain third-line options for refractory cases.

Conclusions

Improved knowledge of the efficacy, safety, and tolerability of the six approved medications may support more appropriate, individualized, and goal-oriented pharmacological management of patients with AUD. The proposed algorithms are intended as pragmatic tools to aid clinical decision-making rather than as formal guidelines.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alcohol DeterrentsAlcoholismAlgorithmsHumansAcamprosateBaclofenDisulfiramNaltrexoneSodium Oxybate

Stichwörter der Autor:innen

alcohol use disorderapproved medicationspersonalized pharmacotherapy

Substanzen

AcamprosateAlcohol DeterrentsBaclofenDisulfiramnalmefeneNaltrexoneSodium Oxybate

Autor:innen und Institutionen

  • Centre for the Study and Treatment of Alcohol-Related Diseases, Department of Translational Medicine, University of Ferrara, Via Borsari 46, 44121, Ferrara, Italy.
  • Department of Internal Medicine, SS Annunziata Hospital, Via Vicini 2, 44042, Cento (Ferrara), Italy.
  • Department of Mental Health and Addiction, AUSL Romagna, Via Ovidio, 47900, Rimini, Italy.
  • Department of Translational Medicine, University of Ferrara, Vai Borsari 46, 44121, Ferrara, Italy.
  • Unit of Addiction and Hepatology, ASL3 c/o Ospedale Policlinico San Martino, Largo Benzi 10, 16132, Genova, Italy.
  • Internal Medicine and Alcohol Related Disease Unit, Columbus-Gemelli Hospital, Fondazione Policlinico Universitario A. Gemelli IRCCS Largo Gemelli 8, 00168, Rome, Italy.

ORCID-Profile: Fabio Caputo, Gianni Testino, Giovanni Addolorato

Förderung

  • University of Ferrara

Zitieren

APA

Caputo, F., Vignoli, T., Lungaro, L., Costanzini, A., Casabianca, A., Caio, G., Testino, G., Addolorato, G., & De Giorgio, R. (2026). Six approved drugs for alcohol use disorder: algorithms for their use according to the aims of treatment. Alcohol and Alcoholism, 61(5). https://doi.org/10.1093/alcalc/agag052

Vancouver

Caputo F, Vignoli T, Lungaro L, Costanzini A, Casabianca A, Caio G, et al. Six approved drugs for alcohol use disorder: algorithms for their use according to the aims of treatment. Alcohol and Alcoholism. 2026;61(5). doi:10.1093/alcalc/agag052

BibTeX
@article{Caputo2026,
  author = {Caputo, Fabio and Vignoli, Teo and Lungaro, Lisa and Costanzini, Anna and Casabianca, Alberto and Caio, Giacomo and Testino, Gianni and Addolorato, Giovanni and De Giorgio, Roberto},
  title = {Six approved drugs for alcohol use disorder: algorithms for their use according to the aims of treatment},
  journal = {Alcohol and Alcoholism},
  year = {2026},
  volume = {61},
  number = {5},
  doi = {10.1093/alcalc/agag052}
}
Kostenlos starten →